Skip to main content
Fig. 2 | Cancer Cell International

Fig. 2

From: LncRNA WDFY3-AS2 promotes cisplatin resistance and the cancer stem cell in ovarian cancer by regulating hsa-miR-139-5p/SDC4 axis

Fig. 2

LncRNA WDFY3-AS2 promoted the cisplatin-resistant in OC cells. A The transfection efficiency of lncRNA WDFY3-AS2 in OC A2780-DDP cells. B CCK8 results of the cell viablity of transfected A2780-DDP cells with cisplatin (20 μM). C Flow cytometric detection of apoptosis of A2780-DDP cells with cisplatin (20 μM). D, E Transwell assay indicated that the invasive and migration activity in A2780-DDP cells with (20 μM) cisplatin treatment (100 μm). ***P < 0.001 vs. control

Back to article page

Cancer Cell International

ISSN: 1475-2867

Contact us